Short Interest in Luye Pharma Group Ltd. (OTCMKTS:LYPHF) Drops By 25.3%

Luye Pharma Group Ltd. (OTCMKTS:LYPHFGet Free Report) was the recipient of a significant decrease in short interest in the month of June. As of June 15th, there was short interest totalling 18,511,300 shares, a decrease of 25.3% from the May 31st total of 24,779,800 shares. Based on an average daily trading volume, of 0 shares, the short-interest ratio is currently ∞ days.

Luye Pharma Group Price Performance

Shares of LYPHF remained flat at $0.37 during midday trading on Friday. The company’s 50-day moving average is $0.38 and its 200 day moving average is $0.39. Luye Pharma Group has a 12-month low of $0.37 and a 12-month high of $0.37.

Luye Pharma Group Company Profile

(Get Free Report)

Luye Pharma Group Ltd., an investment holding company, develops, produces, markets, and sells pharmaceutical products worldwide. The company offers Lipusu for ovarian and breast cancer; CMNa, a chemical sensitizer for cancer radiotherapy; Tiandida for ovarian or non-small cell lung cancer; Boyounuo, an injection for the treatment of various types of cancers and other solid tumors; and Xuezhikang, a lipid-regulating drug for the treatment of hypercholesterolaemia.

Featured Stories

Receive News & Ratings for Luye Pharma Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Luye Pharma Group and related companies with MarketBeat.com's FREE daily email newsletter.